CINC - CinCor Pharma prices upsized stock and pre-funded warrants offering
- CinCor Pharma ( NASDAQ: CINC ) priced its underwritten public offering which was upsized to 7.5M shares and pre-funded warrants from the original offering size of 6M shares and pre-funded warrants.
- The offering consists of 4.9M shares , pre-funded warrants to purchase 2.6M shares at an exercise price of $0.00001; public offering price of each share of common stock is $30 and public offering price of each pre-funded warrant is $29.9/underlying share.
- Underwriters granted 30-day option to purchase up to an additional 1.13M shares.
- Gross proceeds are expected to be ~$225M.
- Offer is expected to close on or about Aug.15, 2022.
For further details see:
CinCor Pharma prices upsized stock and pre-funded warrants offering